Therapeutic Management of a Substantial Pelvic Aneurysmatic Bone Cyst Including the Off-Label Use of Denosumab in a 35-Year-Old Female Patient
Aneurysmal bone cysts (ABC) are benign bone tumors, which are highly vascularized. The main course of treatment is curettage followed by bone grafting or cement insertion. Still recurrence remains a main problem for patients. Denosumab is a monoclonal antibody, which acts as an inhibitor of the RANK...
Saved in:
Main Authors: | D. Ntalos, M. Priemel, C. Schlickewei, D. M. Thiesen, J. M. Rueger, A. S. Spiro |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Orthopedics |
Online Access: | http://dx.doi.org/10.1155/2017/9125493 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Efficacy of Denosumab in the Management of a Tibial Paediatric Aneurysmal Bone Cyst Compromised by Rebound Hypercalcaemia
by: Matthew Harcus, et al.
Published: (2020-01-01) -
A Suspected Pelvic Aneurysmal Bone Cyst in Pregnancy
by: Rayan Elkattah, et al.
Published: (2013-01-01) -
The effect of denosumab vs. zoledronic acid in preventing skeletal-related events, including pain-related bone metastasis: a systematic review
by: I. Putu Eka Widyadharma, et al.
Published: (2024-10-01) -
Pelvic Hydatid Cyst with Hydroureteronephrosis: A Rare Case Report
by: Amir Mohammad Salehi, et al.
Published: (2021-01-01) -
Thermodynamics of the substantial universe
by: V. Yu. Stetsenko
Published: (2024-06-01)